RESUMO
BACKGROUND: Given the limited access to invasive vasospastic reactivity testing in Western Countries, there is a need to further develop alternative non-invasive diagnostic methods for vasospastic angina (VSA). Hyperventilation testing (HVT) is defined as a class IIa recommendation to diagnose VSA by the Japanese Society of Cardiology. METHODS: In this systematic review and meta-analysis reported according to the PRISMA statement, we review the mechanisms, methods, modalities and diagnostic accuracy of non-invasive HVT for the diagnostic of VSA. RESULTS: A total of 106 articles published between 1980 and 2022 about VSA and HVT were included in the systematic review, among which 16 were included in the meta-analysis for diagnostic accuracy. Twelve electrocardiogram-HVT studies including 804 patients showed a pooled sensitivity of 54% (95% confidence intervals [CI]; 30%-76%) and a pooled specificity of 99% (95% CI; 88%-100%). Four transthoracic echocardiography-HVT studies including 197 patients revealed a pooled sensitivity of 90% (95% CI; 82%-94%) and a pooled specificity of 98% (95% CI; 86%-100%). Six myocardial perfusion imaging-HVT studies including 112 patients yielded a pooled sensitivity of 95% (95% CI; 63%-100%) and a pooled specificity of 78% (95% CI; 19%-98%). Non-invasive HVT resulted in a low rate of adverse events, ventricular arrhythmias being the most frequently reported, and were resolved with the administration of nitroglycerin. CONCLUSIONS: Non-invasive HVT offers a safe alternative with high diagnostic accuracy to diagnose VSA in patients with otherwise undiagnosed causes of chest pain.
Assuntos
Vasoespasmo Coronário , Ecocardiografia , Eletrocardiografia , Hiperventilação , Humanos , Hiperventilação/diagnóstico , Hiperventilação/fisiopatologia , Vasoespasmo Coronário/diagnóstico , Vasoespasmo Coronário/fisiopatologia , Angina Pectoris/diagnóstico , Angina Pectoris/fisiopatologia , Sensibilidade e Especificidade , Imagem de Perfusão do MiocárdioRESUMO
Chest pain is the most common symptom of coronary artery disease (CAD) and diabetes mellitus (DM) is a well-known single strongest risk factor for cardiovascular diseases. Thus, the impact of CAD nor DM on long-term clinical effects is reported widely, but the prognostic factors of non-DM patients presenting with chest pain without significant CAD are limited. A total of 1,046 patients with chest pain without DM and significant CAD who underwent coronary angiography (CAG) and acetylcholine (ACH) provocation tests were finally enrolled. Propensity score matching and multivariate Cox-proportional hazard ratio analysis were performed to adjust for baseline potential confounders. Major adverse cardiac and cerebrovascular events (MACCE) were defined as the composite of total death, myocardial infarction (MI), revascularization, stroke, and recurrent angina. This study aimed to evaluate the long-term prognostic factors for MACCE in patients with chest pain without DM and CAD up to 5 years. Coronary artery spasm (CAS) was the most common cause of chest pain. However, long-term MACCE of CAS was not worse than those of patients with chest pain without CAS when patients with CAS had subsequent optimal antianginal medication therapy. However, a recurrent chest pain remains a problem even with continuous antianginal medication therapy. Up to 5 years, the incidence of MACCE was in 7.3%, including recurrent angina 6.9%. Dyslipidemia (HR: 2.010, 95% CI 1.166-3.466, P = 0.012), mild-moderate (30-70%) coronary stenosis (HR: 2.369, 95% CI 1.118-5.018, P = 0.024), the use of aspirin (HR: 2.885, 95% CI 1.588-5.238, P < 0.001), and the use of nitrates (HR: 1.938, 95% CI 1.094-3.433, P = 0.023) were independent risk factors for MACCE. Among the patients with chest pain without DM and significant CAD, the incidence of MACE were rare, but recurrent angina was still a challenging problem who had treated with antianginal medications.
Assuntos
Fármacos Cardiovasculares , Doença da Artéria Coronariana , Estenose Coronária , Vasoespasmo Coronário , Diabetes Mellitus , Humanos , Prognóstico , Doença da Artéria Coronariana/complicações , Angina Pectoris/diagnóstico , Angina Pectoris/epidemiologia , Angina Pectoris/etiologia , Vasoespasmo Coronário/complicações , Vasoespasmo Coronário/diagnóstico , Vasoespasmo Coronário/epidemiologia , Estenose Coronária/diagnóstico , Estenose Coronária/diagnóstico por imagem , Dor no Peito/diagnóstico , Dor no Peito/epidemiologia , Dor no Peito/etiologia , Diabetes Mellitus/epidemiologia , Fatores de Risco , Angiografia Coronária/efeitos adversosRESUMO
We report the case of a 79-year-old male patient who benefited from the implantation of a coronary sinus reducer (CSR) (Reducer; Neovasc, Inc.) in the management of typical angina with mild exertion with optimal medical treatment.
Assuntos
Seio Coronário , Artéria Pulmonar , Masculino , Humanos , Idoso , Seio Coronário/diagnóstico por imagem , Seio Coronário/cirurgia , Angina Pectoris/diagnóstico , Angina Pectoris/etiologia , Angina Pectoris/terapiaRESUMO
BACKGROUND: This study aims to investigate prognostic implications of coronary slow flow (CSF) and angiography-derived index of microcirculatory resistance (caIMR) in patients with angina and normal coronary arteries. METHODS: A total of 582 patients were enrolled with angiographically normal coronary arteries. caIMR was calculated using a commercial software. Patients were followed up for a median of 45 months. The primary endpoint was defined as major adverse cardiovascular events (MACEs) comprising death, myocardial infarction and readmission for angina or heart failure. RESULTS: CSF was diagnosed when TIMI grade 2 flow presented in at least one coronary artery. Multivariate analysis indicated TIMI-flow-based determination of CSF was not significantly associated with MACEs [hazard ratio (HR): 2.14; 95% confidence interval (CI): 0.87-5.31; p = 0.099), while caIMR >42 (HR: 2.53; 95% CI: 1.02-6.32; p = 0.047) were independent predictors of MACEs. Incorporation of caIMR improved the area under the curve from 0.587 to 0.642. CONCLUSIONS: caIMR was an independent prognostic factor of long-term cardiovascular events in patients with CSF. Evaluation of caIMR improved the risk stratification of patients with angiographically-normal coronary arteries.
Assuntos
Doença da Artéria Coronariana , Vasos Coronários , Humanos , Prognóstico , Vasos Coronários/diagnóstico por imagem , Angiografia Coronária , Estudos Retrospectivos , Microcirculação , Angina Pectoris/diagnósticoRESUMO
OBJECTIVE: The goal of the present research was to test the retrospective and prospective associations between the Big Five personality traits and clinical diagnosis of angina while controlling for demographic characteristics. METHODS: Data from middle-aged and older adults from a cohort study Understanding Society: the UK Household Longitudinal Study (UKHLS) were extracted and analyzed using binary logistic regressions (N = 10,124 for the retrospective study and N = 5485 for the prospective study). Personality was measured using a self-report 15-item version of the Big Five inventory between 2011 and 2012. Angina was measured by a self-report clinical diagnosis history question in each wave from until 2019. Covariates in our models included age, sex, income (monthly), education, and marital status. RESULTS: Neuroticism was positively related to the likelihood of clinical angina diagnosis in both the retrospective (OR = 1.22, 95% C.I. [1.11, 1.34]) and the prospective (OR = 1.52, 95% C.I. [1.19, 1.94]) study whereas Extraversion had a positive association with odds of angina (OR = 1.52, 95% C.I. [1.17, 1.97]) in the prospective study only. The negative association between Openness and clinical angina diagnosis in the cross-sectional analysis is borderline significant (OR = 0.91, p = 0.048, 95% C.I. [0.83, 1.00]). CONCLUSION: Our research indicated that personality traits are associated with the risk of angina. These findings emphasize the importance of considering personality traits in understanding the etiology of angina and potentially informing personalized prevention and intervention strategies.
Assuntos
Angina Pectoris , Personalidade , Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Angina Pectoris/psicologia , Angina Pectoris/diagnóstico , Idoso , Estudos Retrospectivos , Estudos Prospectivos , Estudos Longitudinais , Neuroticismo , Extroversão Psicológica , Inventário de Personalidade , AutorrelatoRESUMO
BACKGROUND: Clinical management of patients with angina and no obstructive coronary artery disease (ANOCA) is still challenging. This scenario affects up to 50% of patients undergoing diagnostic coronary angiography due to suspected coronary artery disease. Many patients report a long and debilitating history before adequate diagnostics and management are initiated. OBJECTIVES: This article describes the current recommendations for diagnostic assessments and treatment in patients with ANOCA. Focus is placed on invasive diagnostics in the catheter laboratory, pharmacological/interventional treatment as well as the patient journey. RESULTS: In patients with ANOCA, the current European Society of Cardiology (ESC) guidelines suggest that invasive assessments using acetylcholine and adenosine for the diagnosis of an underlying coronary vasomotor disorder should be considered. Acetylcholine is used to diagnose coronary spasm, whereas adenosine is used in conjunction with a wire-based assessment for the measurement of coronary flow reserve and microvascular resistance. The invasive assessments allow the determination of what are referred to as endotypes (coronary spasm, impaired coronary flow reserve, enhanced microvascular resistance or a combination thereof). Establishing a diagnosis is helpful to: (a) initiate targeted treatment to improve quality of life, (b) reassure the patient that a cardiac cause is found and (c) to assess individual prognosis. CONCLUSIONS: Currently, patients with ANOCA are often not adequately managed. Referral to specialised centres is recommended to prevent long and debilitating patient histories until expertise in diagnosis and treatment becomes more widespread.
Assuntos
Angina Pectoris , Angiografia Coronária , Humanos , Angiografia Coronária/métodos , Angina Pectoris/terapia , Angina Pectoris/diagnóstico por imagem , Angina Pectoris/diagnóstico , Vasoespasmo Coronário/diagnóstico por imagem , Vasoespasmo Coronário/diagnóstico , Vasoespasmo Coronário/terapia , Acetilcolina , Adenosina/administração & dosagemRESUMO
Angina contributes to significant morbidity worldwide. The evaluation of angina is variable and complicated by multiple factors. The diagnosis is often focussed on epicardial disease despite the knowledge that chest pain can be due to cardiac, non-cardiac, macro, and microvascular causes. Standardised diagnostic pathways and novel approaches to angina assessment may offer the opportunity to improve our understanding of angina and apply a personalised approach to treatment.
Assuntos
Angina Pectoris , Doença da Artéria Coronariana , Valor Preditivo dos Testes , Humanos , Angina Pectoris/epidemiologia , Angina Pectoris/diagnóstico , Angina Pectoris/terapia , Doença da Artéria Coronariana/epidemiologia , Doença da Artéria Coronariana/diagnóstico , Doença da Artéria Coronariana/terapia , Fatores de Risco , Resultado do Tratamento , PrognósticoRESUMO
OBJECTIVE: This study investigated differences in clinical outcomes between mixed angina (MA) and pure vasospastic angina (PVA). METHODS: A total of 524 vasospastic angina patients who did or did not have >50% coronary artery stenosis from January 2005 to January 2021 were divided into two groups (Group 1: PVA, N â =â 399; Group 2: MA, N â =â 125) and then three groups [Group 1: PVA, N â =â 399; Group 2: MA without percutaneous coronary intervention (PCI), N â =â 67; Group 3: MA with PCI, N â =â 58] for assessment. We recorded the incidence of major adverse cardiac and cerebrovascular events (MACCE: the composite of death, myocardial infarction, nonfatal stroke or rehospitalization) during 3-year clinical follow-up. RESULTS: Compared to the PVA group, there were significant differences in MACCE (20.8% vs. 11.8%, P â =â 0.011) and rehospitalization (20.0% vs. 9.8%, P â =â 0.002) in the MA group. Kaplan-Meier analysis showed that patients in the MA with PCI group had the highest cumulative incidence rate of MACCE during the 3-year follow-up (log-rank P â <â 0.001). CONCLUSION: Compared with the PVA patients, MA patients had significantly worse clinical outcomes during long-term follow-up.
Assuntos
Intervenção Coronária Percutânea , Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Intervenção Coronária Percutânea/métodos , Idoso , Angina Pectoris/epidemiologia , Angina Pectoris/terapia , Angina Pectoris/diagnóstico , Vasoespasmo Coronário/fisiopatologia , Vasoespasmo Coronário/epidemiologia , Estudos Retrospectivos , Incidência , Resultado do Tratamento , Readmissão do Paciente/estatística & dados numéricos , Fatores de Risco , Estenose Coronária/terapia , Estenose Coronária/complicações , Estenose Coronária/epidemiologia , Estenose Coronária/mortalidade , Infarto do Miocárdio/terapia , Infarto do Miocárdio/epidemiologia , Infarto do Miocárdio/complicaçõesRESUMO
The diagnosis of vasospastic angina (VSA) according to Japanese guidelines involves an initial intracoronary acetylcholine (ACh) provocation test in the left coronary artery (LCA) followed by testing in the right coronary artery (RCA). However, global variations in test protocols often lead to the omission of ACh provocation in the RCA, potentially resulting in the underdiagnosis of VSA. This study assessed the validity of the LCA-only ACh provocation approach for the VSA diagnosis and whether vasoreactivity in the LCA aids in determining further provocation in the RCA. A total of 273 patients who underwent sequential intracoronary ACh provocation testing in the LCA and RCA were included. Patients with a positive ACh provocation test in the LCA were excluded. Relations between vasoreactivity in the LCA and ACh test outcomes (positivity and adverse events) in the RCA were evaluated. In patients with negative ACh test results in the LCA, subsequent ACh testing was positive in the RCA in 23 of 273 (8.4%) patients. In patients with minimal LCA vasoconstriction (<25%), only 3.0% had a positive ACh test in the RCA, whereas the ACh test in the RCA was positive in 13.5% of those with LCA constriction of 25% to 90% (p = 0.002). No major adverse events occurred during ACh testing in the RCA. In conclusion, for the VSA diagnosis, the omission of ACh provocation in the RCA may be clinically acceptable, particularly when vasoconstriction induced by ACh injection was minimal in the LCA. Further studies are needed to define ACh provocation protocols worldwide.
Assuntos
Acetilcolina , Vasoespasmo Coronário , Vasos Coronários , Vasoconstrição , Humanos , Acetilcolina/administração & dosagem , Acetilcolina/farmacologia , Feminino , Masculino , Vasoespasmo Coronário/diagnóstico , Vasoespasmo Coronário/fisiopatologia , Vasoespasmo Coronário/induzido quimicamente , Vasos Coronários/fisiopatologia , Vasos Coronários/efeitos dos fármacos , Idoso , Pessoa de Meia-Idade , Vasoconstrição/fisiologia , Vasoconstrição/efeitos dos fármacos , Angiografia Coronária , Vasodilatadores/administração & dosagem , Estudos Retrospectivos , Angina Pectoris/fisiopatologia , Angina Pectoris/diagnósticoRESUMO
BACKGROUND: Cilostazol has a vasodilatory function that may be beneficial for patients with vasospastic angina (VSA). We conducted a randomized, open-label, controlled trial to compare the efficacy and safety of long-acting cilostazol and isosorbide mononitrate (ISMN) for VSA. METHODS: The study included patients with confirmed VSA between September 2019 and May 2021. Participants were randomly assigned to receive long-acting cilostazol (test group, 200â mg once daily) or conventional ISMN therapy (control group, 20â mg twice daily) for 4â weeks. The clinical efficacy and safety were evaluated using weekly questionnaires. RESULTS: Forty patients were enrolled in the study (long-acting cilostazol, n â =â 20; ISMN, n â =â 20). Baseline characteristics were balanced between the two groups. Long acting cilostazol showed better angina symptom control within the first week compared to ISMN [reduction of pain intensity score, 6.0 (4.0-8.0) vs. 4.0 (1.0-5.0), P â =â 0.005; frequency of angina symptom, 0 (0-2.0) vs. 2.0 (0-3.0), P â =â 0.027, respectively]. The rate of neurological adverse reactions was lower in the cilostazol group than in the ISMN group (headache or dizziness, 40 vs. 85%, P â =â 0.009; headache, 30 vs. 70%, P â =â 0.027). CONCLUSION: Long-acting cilostazol provided comparable control of angina and fewer adverse neurologic reactions within 4â weeks compared to ISMN. Long-acting cilostazol provides more intensive control of angina within 1â week, suggesting that it may be an initial choice for the treatment of VSA.
Assuntos
Cilostazol , Vasoespasmo Coronário , Dinitrato de Isossorbida , Vasodilatadores , Humanos , Cilostazol/uso terapêutico , Masculino , Dinitrato de Isossorbida/análogos & derivados , Dinitrato de Isossorbida/uso terapêutico , Feminino , Pessoa de Meia-Idade , Vasodilatadores/uso terapêutico , Vasodilatadores/administração & dosagem , Vasodilatadores/efeitos adversos , Vasoespasmo Coronário/fisiopatologia , Vasoespasmo Coronário/tratamento farmacológico , Vasoespasmo Coronário/diagnóstico , Idoso , Resultado do Tratamento , Angina Pectoris/tratamento farmacológico , Angina Pectoris/fisiopatologia , Angina Pectoris/diagnóstico , Preparações de Ação RetardadaRESUMO
BACKGROUND: Angina with no obstructive coronary disease (ANOCA) and ischemia with no obstructive coronary disease, prevalent yet underrecognized conditions, mostly affect women. Previous studies rarely distinguished between them. We aimed to compare the prevalence of objective ischemia through various examinations in women with ANOCA and assess the impact of objective and subjective ischemia on their mental health. METHODS AND RESULTS: A total of 84 eligible women with ANOCA and 42 controls underwent mental stress, pharmacological stress, exercise stress, and Holter testing. Objective evidence of myocardial ischemia was assessed by positron emission tomography-computed tomography and ECG, and subjective symptoms were graded using the Canadian Cardiovascular Society scale (CCS). Psychological assessments were conducted using 6 scales. Among 84 women with ANOCA, 37 (44%) received a diagnosis of ischemia with no obstructive coronary disease following mental stress testing, 20 (28.6%) through pharmacological stress testing, 14 (21.2%) via exercise stress testing, and 24 (32.9%) from Holter. Mental stress-induced myocardial ischemia was more prevalent (P<0.05). Among 54 patients with ANOCA who completed all tests, 30% showed no ischemia, and only 1 (1.9%) showed ischemia in all tests. In addition, patients with ANOCA had higher psychological scores than controls (P<0.01). No significant differences was observed in psychological scores between ANOCA with positive and negative ischemia test results (P>0.05). However, ANOCA with milder angina (CCS I) exhibited higher scores across the Hospital Anxiety and Depression Scale, State-Trait Anxiety Inventory, Perceived Stress Scale, and Posttraumatic Stress Disorder Checklist-Civilian Version and a higher prevalence of Type D personality traits (P<0.05). CONCLUSIONS: In patients with ANOCA, the positive rate of myocardial ischemia exhibits variability among several noninvasive tests. A worsened psychological state is more closely linked to milder angina symptoms than to ischemia performance, highlighting the importance of focusing on symptom management in their psychological care. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03982901.
Assuntos
Angina Pectoris , Teste de Esforço , Isquemia Miocárdica , Humanos , Feminino , Pessoa de Meia-Idade , Isquemia Miocárdica/psicologia , Isquemia Miocárdica/epidemiologia , Isquemia Miocárdica/diagnóstico , Angina Pectoris/psicologia , Angina Pectoris/epidemiologia , Angina Pectoris/diagnóstico , Prevalência , Idoso , Angústia Psicológica , Eletrocardiografia Ambulatorial , Estudos de Casos e Controles , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Estresse Psicológico/epidemiologiaRESUMO
BACKGROUND: Invasive CFT is the gold standard for diagnosing coronary vasomotor dysfunction in patients with ANOCA. Most institutions recommend only testing the left coronary circulation. Therefore, it is unknown whether testing multiple coronary territories would increase diagnostic yield. OBJECTIVES: The aim of this study was to evaluate the diagnostic yield of multivessel, compared with single-vessel, invasive coronary function testing (CFT) in patients with angina and nonobstructive coronary arteries (ANOCA). METHODS: Multivessel CFT was systematically performed in patients with suspected ANOCA. Vasoreactivity testing was performed using acetylcholine provocation in the left (20 to 200 µg) and right (20 to 80µg) coronary arteries. A pressure-temperature sensor guidewire was used for coronary physiology assessment in all three epicardial vessels. RESULTS: This multicenter study included a total of 228 vessels from 80 patients (57.8 ± 11.8 years of age, 60% women). Compared with single-vessel CFT, multivessel testing resulted in more patients diagnosed with coronary vasomotor dysfunction (86.3% vs 68.8%; P = 0.0005), coronary artery spasm (60.0% vs 47.5%; P = 0.004), and CMD (62.5% vs 36.3%; P < 0.001). Coronary artery spasm (n = 48) predominated in the left coronary system (n = 38), though isolated right coronary spasm was noted in 20.8% (n = 10). Coronary microvascular dysfunction (CMD), defined by abnormal index of microcirculatory resistance and/or coronary flow reserve, was present 62.5% of the cohort (n = 50). Among the cohort with CMD, 27 patients (33.8%) had 1-vessel CMD, 15 patients (18.8%) had 2-vessel CMD, and 8 patients (10%) had 3-vessel CMD. CMD was observed at a similar rate in the territories supplied by all 3 major coronary vessels (left anterior descending coronary artery = 36.3%, left circumflex coronary artery = 33.8%, right coronary artery = 31.3%; P = 0.486). CONCLUSIONS: Multivessel CFT resulted in an increased diagnostic yield in patients with ANOCA compared with single-vessel testing. The results of this study suggest that multivessel CFT has a role in the management of patients with ANOCA.
Assuntos
Acetilcolina , Angina Pectoris , Doença da Artéria Coronariana , Circulação Coronária , Vasoespasmo Coronário , Vasos Coronários , Valor Preditivo dos Testes , Vasodilatadores , Humanos , Feminino , Masculino , Pessoa de Meia-Idade , Idoso , Vasos Coronários/fisiopatologia , Vasos Coronários/diagnóstico por imagem , Vasodilatadores/administração & dosagem , Vasoespasmo Coronário/fisiopatologia , Vasoespasmo Coronário/diagnóstico , Acetilcolina/administração & dosagem , Angina Pectoris/fisiopatologia , Angina Pectoris/diagnóstico , Angina Pectoris/etiologia , Doença da Artéria Coronariana/fisiopatologia , Doença da Artéria Coronariana/diagnóstico , Doença da Artéria Coronariana/diagnóstico por imagem , Doença da Artéria Coronariana/terapia , Cateterismo Cardíaco , Angiografia Coronária , Reprodutibilidade dos Testes , Vasodilatação , VasoconstriçãoAssuntos
Intervenção Coronária Percutânea , Humanos , Angina Pectoris/terapia , Angina Pectoris/fisiopatologia , Angina Pectoris/diagnóstico , Angiografia Coronária , Doença da Artéria Coronariana/terapia , Doença da Artéria Coronariana/diagnóstico , Doença da Artéria Coronariana/cirurgia , Reserva Fracionada de Fluxo Miocárdico/fisiologia , Intervenção Coronária Percutânea/efeitos adversos , Estudos Prospectivos , Projetos de Pesquisa , Fatores de Tempo , Resultado do Tratamento , Estudos Multicêntricos como AssuntoRESUMO
A angiotomografia de coronárias emergiu recentemente como ferramenta para avaliação não invasiva da anatomia coronariana, para estratificação de risco cardiovascular e para acompanhamento dos pacientes portadores de stent e enxerto cirúrgico, fornecendo dados diagnósticos com boa acurácia. O método apresenta boa resolução temporal e espacial, o que tem contribuído para seu avanço na prática clínica. Permite visualização direta do stent, quantificação de reestenose intra-stent, além de informar sobre a patência dos enxertos cirúrgicos, entre outros propósitos. Este artigo revisa as aplicações e possíveis contribuições deste método em pacientes submetidos à revascularização miocárdica
The coronary computed tomography angiography has recently emerged as a tool for the non- -invasive evaluation of coronary anatomy, stratification of cardiovascular risk and for following up patients with coronary stent and bypass grafting, providing diagnostic data with accurate diagnostic perfomance. This method has a good temporal and spatial resolution, which has allowed advance in clinical practice. Its enables direct visualization of stent, quantification of in-stent restenosis, besides the assessment of graft patency, among others purposes. This article reviews the applications and the potencial contributions of this technique in patients submitted to myocardial revascularization
Assuntos
Humanos , Doença da Artéria Coronariana/mortalidade , Stents , Angiografia por Tomografia Computadorizada/métodos , Revascularização Miocárdica/métodos , Prognóstico , Próteses e Implantes , Cálcio/análise , Fatores de Risco , Vasos Coronários , Diagnóstico , Angina Pectoris/diagnósticoRESUMO
A angiotomografia coronária (CTA) é um método diagnóstico não-invasivo com elevada acurácia na detecção da doença arterial coronária (DAC). Pacientes com DAC não-obstrutiva ou obstrutiva identificadas pela CTA apresentam prognóstico progressivamente pior que os pacientes com CTA normal. A investigação de angina em pacientes de risco baixo e intermediário utilizando CTA como primeiro exame resultou em taxa de mortalidade similar à investigação com métodos funcionais. No entanto, estudos recentes mostraram que pacientes com investigação e tratamento baseados na CTA podem apresentar menor taxa de infarto miocárdico fatal e não-fatal quando comparados aos pacientes investigados e tratados conforme resultados de métodos diagnósticos que avaliam isquemia miocárdica. No contexto do paciente ambulatorial, diretrizes brasileiras e internacionais propõe a CTA como primeiro exame na investigação de DAC, no paciente com avaliação funcional prévia, na avaliação pré-operatória, na diferenciação entre cardiopatias isquêmicas e não isquêmicas e na avaliação de origem anômala de artéria coronária
Coronary computed tomography angiography (CCTA) is a non invasive diagnostic test with high accuracy in the detection of coronary artery disease (CAD). Non obstructive or obstructive CAD detected by CCTA portends increasingly worse prognosis than a normal CCTA. The evaluation of low- and moderate-risk patients with stable angina using CCTA as a first test resulted in similar rates of death when compared to functional tests. However, recent studies have shown that patients evaluated by and treated according to CCTA results may develop lower rates of fatal and non fatal myocardial infarction when compared to patients submitted to and treated according to functional tests. In the context of outpatients, Brazilian and international guidelines propose CCTA as the first diagnostic test in the evaluation of CAD, in patients with previous functional tests, in the preoperative diagnostic workup, in the differentiation between ischemic and non ischemic cardiomyopathy and in the evaluation of anomalous coronary artery origin